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This article is protected by copyright. All rights reserved. domain. Ligand binding triggers receptor heterodimerization [5] and initiates downstream signaling events via the two TIR domains [6] , which recruit MyD88 and signal through IL-1R-associated kinases (IRAK) to initiate p38 MAPK and NF-B-mediated responses [3, 7] .
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IL-18 expression is up-regulated in a range of inflammatory and autoimmune diseases (for recent reviews see [3, 8] ), including inflammatory bowel disease (IBD), the two major forms of which are
Crohn's disease (CD) and ulcerative colitis (UC) [9, 10] . IL-18 expression is notably increased in mucosal biopsies of IBD patients compared with those of control patients, but also in inflamed versus non-inflamed intestinal tissues of IBD patients [9, 10] . The predominant source of IL-18 in IBD is thought to be intestinal epithelial cells, however in CD patients during the late and most severe phase of the disease, lamina propria (LP) macrophages and dendritic cells become an additional source of this cytokine [9] . Further we have recently demonstrated high levels of IL-18 expression in lymphoid follicles in the LP of CD patients in close association with CD4 + T cells [11] .
IL-18 expression is also increased in animal models of IBD [12] [13] [14] and, depending on the model, has been reported to have either pro or anti-inflammatory activities [15, 16] . A possible explanation for these results is that IL-18 may have distinct functions depending on the stage of the disease, the cellular sources of IL-18 and the presence of specific IL-18R-expressing effector cells [9, [17] [18] [19] [20] [21] .
Subsets of CD4 + T helper cells in both humans and mice express IL-18R [11, 22, 23] and we recently demonstrated that most CD4 + T cells in the healthy and inflamed human intestine express IL-18R and thus represent a potentially important IL-18-responsive population in IBD [11] . Regarding direct effects on CD4 + T cells, IL-18 promotes both Th1 and Th2 development [24] and synergizes with IL-12 to drive the proliferation of and IFN-γ production by Th1 cells in the context of T cell receptor (TCR) stimulation [7] . Interestingly in human effector/memory CD4 + T cells, IL-18 in combination with IL-12 can induce IFN- production and can synergize with IL-23 to induce potent IL-17 production from Th17-polarized effectors, independently of TCR stimulation, a property often referred to as "innate responsiveness" [7, [25] [26] [27] . In this regard, we recently demonstrated that IL-15
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or the TNF-like ligand 1a (TL1a), together with IL-12/IL-18, induce the production of a wide range of cytokines in human intestinal CD4 + T cells, in a TCR independent but IL-18 dependent manner [11] . The role of IL-18 dependent innate CD4 + T cell responses in the setting of intestinal inflammation is however unclear.
In the current study we assess the role of IL-18Rα expression by murine CD4 + T cells in cytokine-induced cytokine production and its contribution to driving inflammation in vivo during
This article is protected by copyright. All rights reserved. To determine which subsets of murine CD4 + T cells express IL-18Rα and are thus potentially responsive to IL-18, cells were isolated from murine MLN, spleen, small intestinal lamina propria (siLP) and cLP and IL-18Rα expression assessed by FACS (Fig. 1) . IL-18Rα was expressed on a small proportion of total splenic and MLN CD4 + T cells (Fig. 1A) and further sub-setting of these cells revealed high IL-18Rα expression on 20-40% of central memory and effector memory, but not naïve, CD4 + T cells (Fig.1B and C, data not shown) . Specificity of the IL-18R staining was confirmed by the absence of staining on IL-18R -/-cells (Supporting Information Fig. 1A) . In contrast to MLN and spleen, a large fraction of the steady state cLP and siLP CD4 + T cells expressed high levels of IL-18R (Fig. 1D) . The majority of the intestinal CD4 + T cells displayed an effector/memory phenotype and this was unaltered in IL-18Rα -/-mice (Supporting Information Fig. 
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Further, all cLP CD4 + IL-18Rα + cells exhibited an effector/memory phenotype (Supporting Information Fig. 1D-F (Fig. 1 E-G) .
Collectively these results demonstrate that IL-18R hi CD4 + T cells are enriched in the intestinal mucosa compared with MLN and spleen, and that IL-18Rexpression is not restricted to a specific functional subset of intestinal CD4 + T cells
IL-18Rα is induced preferentially on activated OT-II CD4 + T cells localizing to the intestinal LP.
8
To gain further insights into the regulation of IL-18Rα expression on CD4 + T cells, naïve OVAspecific OT-II cells were labelled with violet cell tracer (VCT) and injected i.v. into congenic recipients. One day later recipient mice were immunized with OVA i.p or by oral gavage together with the TLR7/8 agonist R848 (oral) or LPS and anti-CD40 mAb (i.p) ( Fig. 2A) . IL-18R expression was then assessed on responding OT-II cells four, seven and twelve days after immunization. While injected OT-II cells did not express IL-18Rα ( Fig. 2A) , OT-II cells expressing high levels of IL-18R
were readily detected in the siLP but not MLN or spleen at day 7 and 12 after oral immunization ( Fig.   2B-D) . Similar results were obtained after i.p. immunization of animals with OVA + anti-CD40 + LPS and confirmed that OT-II cells start to express IL-18Rα relatively late after activation and primarily upon localization to the intestine ( Fig. 2E-F) . IL-18Rα, was also detected on a minor subset of OT-II cells in the MLN, PP, spleen suggesting some degree of IL-18Rα upregulation in these tissues or that these cells represent OT-II cells that have first circulated through intestinal sites.
Finally a significant proportion of OT-II cells also started expressing high levels of IL-18Rα in the lungs after i.p. immunization, but to a lesser extend compared to siLP OT-II cells (Fig. 2E-F ).Together these results suggest that IL-18Rα is induced on CD4 + T cells subsequent to their entry into the intestinal mucosa.
Cytokine-induced cytokine production by intestinal CD4 + T cells is diminished in IL-18R -/-mice.
To determine whether IL-18R expression impacted on the number and proportion of colonic CD4 + T cell subsets, we next compared the composition of cLP CD4 + T cells in IL-18R -/-and WT littermate controls (Fig. 3A) . The absolute numbers of CD4 + T cells in the cLP of IL-18R -/-mice did not differ
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2B). Previous reports have suggested that the synergy between IL-12
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and IL-18 in driving IFN-γ production may be related to the capacity of IL-12 to up-regulate IL-18Rα
in mouse Th1 cells [28, 29] . While cLP CD4 + T cells, stimulated with IL-12+IL-18 ± IL-15+TL1a
showed a trend towards enhanced IL-18Rα expression compared with medium alone, this did not reach statistical significance (Supporting Information Fig. 2C-D) . In comparison, expression of IL-15Rα was not regulated by addition of any of the cytokines (Supporting Information Fig. 2C-D) .
Collectively these results suggest an important role for IL-18R in cytokine-induced cytokine production by intestinal LPMC and cytokine-induced IFN- and IL-17 production by intestinal LP CD4 + T cells.
IL-18Rα is expressed on most intestinal CD4 + T cells during experimental colitis.
To assess whether IL-18Ris expressed on intestinal CD4 + T cells during experimental colitis, WT CD45RB hi CD4 + T cells were injected into RAG -/-recipients and IL-18R expression on donor CD4 + T cells was assessed in the MLN and cLP after 6-7 weeks (Fig. 4A) , a time point where mice had developed active colitis. IL-18R was expressed at high levels on the majority of CD4 + T cells in the cLP and MLN (Fig. 4A) . Furthermore IL-18R was expressed on almost all effector CD4 + T cells, irrespective of whether they produced IFN-, IL-17 or both cytokines ( Fig. 4B-C (data not shown), indicating that the high proportions of IL-18R-expressing T cells was a result of the RAG -/-lymphopenic and not of the chronic inflammatory environment.
IL-18Rα signaling in CD4 + T cells is dispensable for the induction of T-cell-mediated colitis.
Given the fact that IL-18R was expressed on the vast majority of IFN--and IL-17-producing CD4 + T cells in the MLN and cLP of colitic mice (Fig. 4B-C assessed by histological score ( Fig. 4D and E) . In addition, the total numbers of CD4 + T cells accumulating in the MLN and cLP of colitic mice were similar between both groups of recipient mice ( Fig. 4F ) Quantitative PCR analyses on total colon tissue showed that the absence of IL-18Rα signaling in CD4 + T cells also had no impact on the production of IL-12 and IL-23 mRNA in the cLP (data not shown). FACS analyses revealed that IL-18Rα deficiency had no impact on the Th1/Th17/Treg cell balance in the MLN, 6-7 weeks after transfer ( Fig. 4G-J) . In contrast, the cLP of (Fig. 4 G-J) .
Collectively these results demonstrate that although IL-18R signaling in CD4 + T cells is required for the optimal generation of Th1 cells, it is dispensable for colitogenic function of CD4 + T cells in this model.
IL-18Rα is required for cytokine-induced cytokine production by colonic intestinal CD4 + T cells during inflammation.
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DISCUSSION
We recently reported that a large proportion of CD4 + T cells from the healthy and inflamed human intestine expresses IL-18Rα and a key role for IL-18 in TCR independent cytokine induced pro-inflammatory cytokine production by these cells [11] . The purpose of the current study was thus to evaluate whether this TCR-independent, IL-18-dependent, innate responsiveness of mucosal This article is protected by copyright. All rights reserved.
14 to synergize with IL-12 to promote the proliferation and IFN-γ production by Th1 cells in the context of TCR stimulation [7] . In addition, as we show here, IL-18 together with IL-12, in a TCR independent manner, dramatically enhances IFN- production by intestinal CD4 + T cells. Thus IL-18 may, in a TCR independent manner, promote the expansion and/or maintenance of Th1 cells in the context of colitis.
The mechanism by which IL-12 and IL-18 synergize to promote CD4 + T cell functionality has been proposed to involve the reciprocal up-regulation of IL-18Rα and IL-12Rβ2 by IL-12 and IL-18 signaling respectively in committed Th1 cells [28, 29, 35] , as well as synergistic intracellular signaling pathways directly activating the IFN-γ promoter [7, 36] . In addition, IL-18 has been shown to stabilize IFN-γ mRNA through the activation of MAPK p38 [37] and to increase Th1 cell proliferation by stimulating their production of IL-2 [38] .
Finally Yang et. al recently reported TCR independent IL-12 and IL-18 synergy to be dependent on IL-18-induced synthesis of GADD45β
(MyD118, related member of a family of proteins that activate MAPK kinase kinases), which maintained a prolonged activation of p38 MAPK [39] . The prolonged p38 MAPK activation is a requirement for cytokine-induced but not in TCR-induced prolonged IFN-γ transcription [39] . In the current study, we found that cLP CD4 + T cells incubated with IL-12 and IL-18 or IL-12/IL-18/IL-15
and TL1a lead to a slight increase in IL-18Rα expression compared to medium alone, although changes were not significant. Further our attempts to assess p38 MAPK phosphorylation in cytokinestimulated cLP CD4 + were highly variable and inconclusive, potentially as a result of the lengthy isolation procedure of these cells. hypothesize that yet to be identified commensals present in our animal facility are stimulating Th17 differentiation via pathways that cannot be blocked by IL-18Rα signaling.
Regarding the regulation of IL-18Rα expression, our results suggest that IL-18Rα induction on CD4 + T cells is not simply a consequence of late stage T activation but rather of the environment to which activated T cells localize. High IL-18Rα expression was detected primarily on CD4 + T cells subsequent to their localization to the intestine, irrespective of the route of immunization, indicating that the intestinal environment preferentially retains IL-18Rα hi cells, or promotes the expression of IL-18Rα expression and/or preferential survival of these T cells. Interestingly, the significant proportion of IL-18Rα hi OT-II cells detected at another mucosal site (lungs) after i.p. (Fig. 2E-F) but not oral (data not shown) immunization, suggests that factors driving high IL-18Rα expression could also be present at multiple mucosal sites. Further studies are required to define the mechanism underlying the preferential accumulation of IL-18Rα + T cells in the intestine and putative regulators of IL-18Rα
expression.
In conclusion, we demonstrate a role for IL-18R signaling in CD4 + T cells in the generation of IFN- producing CD4 + T cells during colitis and in cytokine driven innate CD4 + T cell responses in both the steady state and inflammatory setting. Despite these findings we show that IL-18R signaling in CD4 + T cells is dispensable for the induction of T cell mediated colitis. 
MATERIAL AND METHODS
Mice
Flow cytometry and antibodies
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Flow cytometry was performed as previously described [45] . 
Cell isolation
Cell suspensions from MLN, spleen, siLP and cLP were prepared as described previously [46] , 
Adoptive transfer experiments
CD45RB high transfer model of colitis
This article is protected by copyright. All rights reserved. [47] . Mice were sacrificed after 6 to 7 weeks and MLN and colon taken for analysis.
Samples of proximal, mid, and distal colon were collected, fixed in formalin, embedded in paraffin, before preparing cross-sections and further staining with hematoxylin and eosin. The degree of inflammation on microscopic colon section was graded in a blinded fashion to avoid bias, according to a previously described scoring system [48] . Each sample was graded semi-quantitatively from zero to three for four criteria: (1) crypt length, degree of epithelial hyperplasia and goblet cell depletion;
(2) leukocyte infiltration in the lamina propria; (3) area of tissue affected; and (4) presence of markers of severe inflammation such as crypt abscesses, submucosal inflammation, and ulcers. Scores for each criterion were added to give an overall inflammation score for each sample of 0-12. Scores from proximal, mid, and distal colon were averaged to obtain inflammation scores for the colon.
Statistical analysis
All single column comparisons were performed using non-parametric student t-test and all multiple column analyses were performed using ANOVA followed by "Bonferroni's Multiple Comparison
Test" (* p<0.05, ** p<0.01, *** p<0.001). Statistical analysis was performed using GraphPad Prism software (GraphPad, La Jolla, CA). Results are shown as mean ± (SEM) from 2 independent experiments; each symbol represents results from a single mouse. 
